{"entity":{"type":"insider","cik":"0001918845","url":"/insider/0001918845","json_url":"/insider/0001918845.json","name":"Doyle Mittie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":11,"first":"2026-03-18","last":"2026-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Doyle Mittie","source":"filing","n_filings":11,"first_seen":"2026-03-18","last_seen":"2026-08-19"}],"transactions":[{"id":9298270,"accession":"0001918845-26-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001918845-26-000029","line_url":"/filing/0001918845-26-000029#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","total_whole":"20,000","shares_owned_after":51776.0,"shares_owned_after_display":"51,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":9296735,"accession":"0001918845-26-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001918845-26-000026","line_url":"/filing/0001918845-26-000026#line-1","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":679.0,"shares_display":"679","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":13580.0,"total_display":"13,580.00","total_whole":"13,580","shares_owned_after":51776.0,"shares_owned_after_display":"51,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":5819602,"accession":"0001918845-26-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001918845-26-000024","line_url":"/filing/0001918845-26-000024#line-2","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","total_whole":"20,000","shares_owned_after":51776.0,"shares_owned_after_display":"51,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-27","filed_date":"2026-07-29","scope":"insider"},{"id":6066410,"accession":"0001918845-26-000022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001918845-26-000022","line_url":"/filing/0001918845-26-000022#line-3","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4654.0,"shares_display":"4,654","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":93080.0,"total_display":"93,080.00","total_whole":"93,080","shares_owned_after":51776.0,"shares_owned_after_display":"51,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-02","scope":"insider"},{"id":5866206,"accession":"0001918845-26-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001918845-26-000020","line_url":"/filing/0001918845-26-000020#line-2","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1450.0,"shares_display":"1,450","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":26100.0,"total_display":"26,100.00","total_whole":"26,100","shares_owned_after":51776.0,"shares_owned_after_display":"51,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-25","scope":"insider"},{"id":5772135,"accession":"0001918845-26-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001918845-26-000016","line_url":"/filing/0001918845-26-000016#line-2","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":679.0,"shares_display":"679","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10864.0,"total_display":"10,864.00","total_whole":"10,864","shares_owned_after":47122.0,"shares_owned_after_display":"47,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-28","filed_date":"2026-06-01","scope":"insider"},{"id":6032668,"accession":"0001918845-26-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001918845-26-000012","line_url":"/filing/0001918845-26-000012#line-2","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":18.76,"price_display":"18.76","price_state":"stated","total_value":56280.0,"total_display":"56,280.00","total_whole":"56,280","shares_owned_after":3622.0,"shares_owned_after_display":"3,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider"},{"id":6101246,"accession":"0001918845-26-000010","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001918845-26-000010","line_url":"/filing/0001918845-26-000010","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106555.0,"shares_display":"106,555","price_per_share":20.679485756651495,"price_display":"20.68","price_state":"stated","total_value":2203502.6048,"total_display":"2,203,502.60","total_whole":"2,203,503","shares_owned_after":32695.0,"shares_owned_after_display":"32,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-06","filed_date":"2026-05-07","scope":"insider","n_lines":5},{"id":6101232,"accession":"0001918845-26-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001918845-26-000010","line_url":"/filing/0001918845-26-000010#line-3","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1679.0,"shares_display":"1,679","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":26864.0,"total_display":"26,864.00","total_whole":"26,864","shares_owned_after":3622.0,"shares_owned_after_display":"3,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-07","scope":"insider"},{"id":6181822,"accession":"0001918845-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001918845-26-000008","line_url":"/filing/0001918845-26-000008#line-2","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3970.0,"shares_display":"3,970","price_per_share":18.0122,"price_display":"18.01","price_state":"stated","total_value":71508.434,"total_display":"71,508.43","total_whole":"71,508","shares_owned_after":3622.0,"shares_owned_after_display":"3,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-08","scope":"insider"},{"id":5902480,"accession":"0001918845-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001918845-26-000006","line_url":"/filing/0001918845-26-000006#line-2","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":679.0,"shares_display":"679","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10864.0,"total_display":"10,864.00","total_whole":"10,864","shares_owned_after":3622.0,"shares_owned_after_display":"3,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-03","scope":"insider"},{"id":6048315,"accession":"0001918845-26-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001918845-26-000004","line_url":"/filing/0001918845-26-000004#line-3","is_derivative":false,"issuer_cik":"0001534120","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001534120","owner_cik":"0001918845","owner_name":"Doyle Mittie","owner_display_name":"Doyle Mittie","owner_url":"/insider/0001918845","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25492.0,"shares_display":"25,492","price_per_share":16.1465,"price_display":"16.15","price_state":"stated","total_value":411606.578,"total_display":"411,606.58","total_whole":"411,607","shares_owned_after":3622.0,"shares_owned_after_display":"3,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001534120","name":"Avalo Therapeutics, Inc.","url":"/issuer/0001534120","role":"Officer (Chief Medical Officer)","n_filings":11,"first_seen":"2026-03-18","last_seen":"2026-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001918845","retrieved_at":"2026-08-25T09:06:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}